Compare Becton Dickinson and Co (BDX) vs Expensify Inc (EXFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Expensify Inc — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Expensify Inc trades at $2.4 (market cap $209.73M). The key difference: Becton Dickinson and Co is far larger — about 235.6× Expensify Inc's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Expensify Inc pays none. Which is the better fit depends on your goals.
| BDX | EXFY | |
|---|---|---|
Market Cap | $49.41B | $209.73M |
Sector | Health | Technology |
52-Week High | $185.39 | $2.69 |
52-Week Low | $138.62 | $0.75 |
Enterprise Value | $65.51B | $149.35M |
Dividend Yield | 2.32% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Expensify Inc
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →
